Patrick Crowley

Founder and Owner, Callum Consultancy

Patrick Crowley He played significant technical and management roles in the development to commercialisation of over 20 novel medicinal products and Product Line Extensions during a 38-year career in the pharmaceutical industry. Active ingredients in these medications included novel chemical entities, fermentation products, semi synthetics and two biopharmaceuticals. Products covered a full range of types (parenteral, oral, topical etc). He is the named Inventor of a number of Patents related to dosage form design and drug delivery.

Since retiring from GlaxoSmithKline in 2008 as a Vice President in Pharmaceutical Development he has operated as a Consultant for various multinational, mid-size and startup healthcare organizations in "trouble-shooting technical problems", product registrations (filings), dosage form development and patent litigation. He is a Visiting Professor at The School of Pharmacy, Kings College, University of London, teaching classes to Masters students on Biopharmaceuticals and Vaccines.

He is also currently working on a Team (based at King's College) developing an online teaching module for Biopharmaceuticals for Colleges throughout the European Union (PHAR-IN program), assembling the module for biopharmaceutical dosage form design, and manufacture. He is the author or co-author of several publications on various facets of pharmaceutical development.